Rocket Lab
RKLB · NASDAQ
About RKLB
- Employees
- 2,600
- Headquarters
- Long Beach, California
- Listed
- Nov 16, 2020
- Sector
- Industrials
- Industry
- Aerospace & Defense
- Website
- rocketlabcorp.com
RKLB key statistics
- Market cap
- 30.46B
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 22.54M
- Volume
- 16.95M
- Open price
- $50.64
- High today
- $52.72
- Low today
- $49.25
- 52 Week high
- $151.00
- 52 Week low
- $37.57
Rocket Lab (RKLB) at a glance
Rocket Lab (RKLB) last traded at $50.90, with a market cap of 30.46B and a price-to-earnings ratio of 0.00.
Today the stock has traded between $49.25 and $52.72. The current price is 3.4% above the day's low and 3.4% below its high.
Volume so far is 16.95M shares, below the average of 22.54M shares a day.
Over the past year Rocket Lab has ranged from $37.57 to $151.00, and now sits 12% of the way up that range.
Rocket Lab met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported -$0.08 per share against an estimate of -$0.0765.
The average analyst price target is $111.05, 118.2% above the current price, from 20 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy80.0%
- Hold20.0%
- Sell0.0%
- Low
- $64.64
- Now
- $50.90
- High
- $141.75
RKLB earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 19.1% on average.
- Q3 FY24: reported -$0.10 per share against an estimate of -$0.1139
- Q4 FY24: reported -$0.10 per share against an estimate of -$0.104
- Q1 FY25: reported -$0.12 per share against an estimate of -$0.1306
- Q2 FY25: reported -$0.13 per share against an estimate of -$0.1167
- Q3 FY25: reported -$0.03 per share against an estimate of -$0.1064
- Q4 FY25: reported -$0.09 per share against an estimate of -$0.0942
- Q1 FY26: reported -$0.07 per share against an estimate of -$0.0815
- Q2 FY26: reported -$0.08 per share against an estimate of -$0.0765
RKLB news
- Erica Kollmann
- Press releasePRNewswire
Iridium Announces Third Quarter 2026 Results
- Badar Shaikh
Elon Musk Just Dropped a Big Hint About SpaceX’s $28.5 Trillion Opportunity — ‘It Is Vastly Higher Than That’
- Evette Mitkov
Rocket Lab Stock Climbs: What's Happening?
- Press releasePRNewswire
A Speed Cap Nobody Will Own Just Shook Up the Satellite Trade
- Badar Shaikh
Elon Musk Challenges Jeff Bezos' Blue Origin and Other SpaceX Rivals, Says They Still Can’t Catch Starship — ‘Even Their Future Plans Are Behind’
- Crispus Nyaga
Rocket Lab Stock Erases $57 Billion in Value as Headwinds Mount
Benzinga Bulls and Bears: Palantir, Apple, Six Flags
Similar companies
Companies in the same industry as Rocket Lab
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.